DJIA 18,038.84 3.91 0.02%
NASDAQ 5,020.02 25.41 0.51%
S&P 500 2,103.39 2.99 0.14%
market minute promo

Celldex Therapeutics (NASDAQ: CLDX)

28.06 -0.03 (-0.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CLDX $28.06 -0.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $28.25
Previous Close $28.09
Daily Range $27.68 - $28.46
52-Week Range $10.76 - $32.82
Market Cap $2.5B
P/E Ratio -21.28
Dividend (Yield) $0.00 (0.0%)
Volume 153,287
Average Daily Volume 2,034,204
Current FY EPS -$1.54

Sector

Healthcare

Industry

Drug Makers

Celldex Therapeutics (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website: http://www.celldex.com/

News & Commentary

Disruptive Innovation Changing the Fight Against Cancer

After decades of false starts, new immunotherapies are achieving long-lasting remissions in patients with extremely deadly cancers. Some doctors are even daring to use the word "cure."

Health Care Sector Update for 04/20/2015: CLDX, LGND, LLY

US Stock Futures Signal Higher Start On Wall Street

Celldex's Varlilumab Demonstrates Synergistic Anti-Tumor Activity with PD-1 Signaling Blockade in Pr

Celldex's Varlilumab Demonstrates Synergistic Anti-Tumor Activity with PD-1 Signaling Blockade in Preclinical Studies

Celldex Therapeutics Pushes Forward With Varlilumab And Further Proves Its Worth

Exelixis' Cometriq Gets Fast Track Status in U.S. - Analyst Blog

Celldex Initiates Study on Varlilumab for Metastatic Melanoma - Analyst Blog

Stock Index Tracking Red-Hot Cancer Immunotherapy Field Launched

Roth Capital Weighs In On 5 Biotech Stocks To Watch

Roth Capital Weighs In On 5 Biotech Stocks to Watch

See More CLDX News...

CLDX's Top Competitors

CLDX $28.06 (-0.11%)
Current stock: CLDX
AMGN $168.15 (1.31%)
Current stock: AMGN
GILD $103.72 (3.05%)
Current stock: GILD
BIIB $424.20 (0.30%)
Current stock: BIIB